Zepbound contains the same active ingredient, tirzepatide, as Mounjaro, which is also made by Lilly and is FDA-approved to ...
US FDA expands approval for Alnylam's drug to treat rare ... Ozempic from shortage list Drug compounders sued the U.S. Food and Drug Administration on Monday over its decision last week to ...
Two companies have received approved for a generic of the 2.5 mg tablet of anticoagulant rivaroxaban, which is used to reduce ...
Eli Lilly, Adaptimmune, Aurion Biotech, and ImmunityBio had breakthrough medicines and therapies debut in the past year.
The Outsourcing Facilities Association is appealing a ruling that rejected their request for an injunction against the FDA’s ...
With another inflammatory bowel disease (IBD) approval in the bag for Tremfya, Johnson & Johnson continues to make good on ...
The future of American drug innovation is threatened by U.S. regulations that permit knockoff versions of new drugs to be ...
Novartis receives third FDA approval for oral Fabhalta® (iptacopan) – the first and only treatment approved in C3 glomerulopathy (C3G) Fabhalta is the only oral alternative complement pathway ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback